Vowst denied for failing step therapy by Blue Cross Blue Shield?

Blue Cross Blue Shield's specific coverage criteria for vowst are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why BCBS Applies Step Therapy to VOWST — and How to Appeal

VOWST (fecal microbiota spores, live) is FDA-approved to prevent recurrent Clostridioides difficile infection (rCDI). Blue Cross Blue Shield plans often require patients to document failure of prior treatments — typically antibiotic-based CDI therapies — before approving VOWST. This is called step therapy, or "fail-first" policy. The denial means BCBS believes you have not yet met the documented prior-failure requirements in its coverage policy.

## Why This Denial Is Appealable

Step-therapy denials are among the most commonly overturned on appeal. Many states have enacted step-therapy reform laws that prohibit insurers from requiring patients to retry treatments they have already failed, are contraindicated, or that a physician determines are clinically inappropriate. Under ACA §2719 and ERISA §503, you are entitled to a full-and-fair internal review and then an independent external review. The external-review window typically opens after a final internal denial and remains available for approximately four months. Expedited review (often resolved within 72 hours) is available when delay would seriously jeopardize your health.

BCBS must show that its step-therapy protocol is clinically sound and that an exception does not apply. If you have already tried and failed prior therapies, or if your prescriber documents a clinical reason that bypass is appropriate, the plan is obligated to consider that evidence.

## What to Gather

• Diagnosis and episode history: Chart records documenting each episode of CDI, with dates and treating providers.
• Prior-therapy documentation: Dates, specific agents prescribed, duration of each course, and documented outcomes (including recurrence dates and severity after each treatment).
• Clinical severity notes: Physician notes and relevant lab results showing the pattern and severity of recurrence that led to the VOWST prescription.
• Step-therapy exception letter: A letter from your prescriber stating why VOWST is medically necessary now, referencing the FDA-approved labeling and applicable clinical guidelines from the relevant professional society (such as the Infectious Diseases Society of America).
• BCBS coverage policy: Request the exact written step-therapy criteria from BCBS so you can address each requirement directly.

## Criteria-Mapping Structure

Obtain BCBS's step-therapy policy for VOWST in writing. For each required step, document the corresponding chart evidence:

> BCBS required step: [paste verbatim] > Chart evidence of completion or exception: [exact date, agent, outcome, or physician note]

If an exception applies (prior failure, contraindication, or physician-determined clinical inappropriateness), state it explicitly and attach supporting documentation.

## Timeline

Your denial letter states the internal appeal deadline — typically 180 days but confirm the exact date. File immediately. If your condition is urgent, request expedited review in writing. After a final internal denial, file for independent external review to preserve your rights within the applicable window, usually approximately four months from the final denial date.